Precigen Inc (PGEN) financials

NASDAQ · Health Care

$6.94 +4.52% Close Oct 30, 2026 Live

Precigen revenue and earnings by year

Precigen's revenue was $9.68 million in the fiscal year to December 31, 2025, up 146.7% from the year before. Net income was -$251 million, -2588.2% of revenue. Since the fiscal year to December 31, 2016, revenue has shrunk 28.2% a year on average.

RevenueNet income
-$500M-$250M$0
2016201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenue104627143291151219191
Revenue growth146.7%-36.9%-76.9%88.6%-55.4%-64.7%-40.0%-31.1%14.9%—
Gross profit5-00219272989158129
Gross margin50.2%-8.7%1.7%76.4%59.7%83.2%32.3%58.5%71.9%67.7%
Operating income-111-135-100-76-92-87-163-369-96-125
Operating margin-1141.1%-3440.2%-1602.5%-281.4%-644.5%-271.1%-180.0%-244.2%-43.7%-65.6%
Net income-251-126-9628-92-171-322-509-117-187
Net margin-2588.2%-3216.2%-1540.6%105.2%-646.0%-533.0%-355.3%-336.9%-53.3%-97.7%
Diluted EPS-$1.37-$0.47-$0.39$0.14-$0.47-$1.02-$2.09-$3.93-$0.98-$1.57
Free cash flow-90-77-68-69-60-78-173-164-149-80

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open PGEN in Markets.

See also: PGEN returns

No forecast, no recommendation. This page describes Precigen Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.